Hisham Sweidan

Venous Thromboembolism in Patients Receiving Vascular Endothelial Growth Factor-Targeted Therapy

Vascular endothelial growth factor (VEGF)-targeted therapies have been associated with thromboembolic events, although the magnitude and nature of this risk vary substantially according to the specific agent, mechanism of VEGF-pathway inhibition, malignancy, concomitant therapy,...